ReviewArchives of medical sciences. Atherosclerotic diseases2025

Efficacy and safety of myosin inhibitors for symptomatic hypertrophic cardiomyopathy: systematic review and meta-analysis.

Mohammad Hazique et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.